Amazing Results with Hydroxyurea Therapy in Chronic Hepatitis B: A Preliminary Report


Hessam Hassanzadeh Kashani 1 , * , Aliakbar Vossoughi 2 , Peyman Adibi 2 , Seyed Moayed Alavian 2

1 Department of Gastroenterology and Liver Diseases, AJA University of Medical Sciences, [email protected], Tehran, IR-Iran

2 Gastroenterology Section,Department of Medicine, Isfahan University of Medical Sciences, IR-Iran

How to Cite: Kashani H, Vossoughi A, Adibi P, Alavian S. Amazing Results with Hydroxyurea Therapy in Chronic Hepatitis B: A Preliminary Report, Hepat Mon. Online ahead of Print ; 10(3):215-217.


Hepatitis Monthly: 10 (3); 215-217
Article Type: Brief Report
Received: March 10, 2010
Accepted: April 6, 2010




Background and Aims: To introduce the possible role of hydroxyurea (HU), a well-characterized antineoplastic drug with established antiviral effects, in the treatment of chronic hepatitis B.

Methods: Four antiretroviral-naïve patients with chronic hepatitis B were enrolled in this limited pilot trial, and given 1000 mg/day of hydroxyurea for 4 weeks; then, the administration of the drug was suspended for 4 weeks. A clinical study and laboratory safety assessments and measurements of viral load were made at baseline, after drug therapy, and after one month suspension of the treatment.

Results: All 4 patients showed a significant decrease in viral load after 4 weeks of hydroxyurea therapy and the viral load of 2 patients increased again after a 4-week suspension of hydroxyurea.

Conclusions: Our data demonstrate that the old low-cost antineoplastic drug, hydroxyurea, efficiently blocks hepatitis B virus (HBV) replication. We suggest that HU will play an important role in the treatment of chronic hepatitis in the fore- seeable future. Further studies including those that evaluate optimal dosing in long-term use will continue to define the role of HU in the treatment of HBV infection alone or in combination with other antiviral drugs.


HBV Chronic Hepatitis B Hydroxyurea Antiviral Therapy

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF